Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Lok

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
The Utility of Liquid Biopsies in Radiation OncologySteven De Michino, Mansi Aparnathi, Ariana Rostami, et al.
Nature Reviews. Clinical Oncology|May 24, 2017
Unravelling the biology of SCLC: implications for therapyJoshua K Sabari, Benjamin H Lok, James H Laird, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|January 13, 2009
Gastric banding with simultaneous panniculectomy: two case reports on techniqueAllison M Carelli, Laki J Rousou, Benjamin H Lok, et al.
Cancer Medicine|January 1, 2019
Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignanciesJennifer Ma, James H Laird, Karen W Chau, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of InvolvementJames Laird, Jennifer Ma, Karen Chau, et al.
Cancer & Metabolism|June 24, 2026
CRISPR screen identifies autophagy inhibition (GNS561) as a PARP inhibitor (AZD5305) combination strategy in small cell lung cancerTony Yu, Ranya Barayan, Lifang Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and XenograftsJames H Laird, Benjamin H Lok, Jennifer Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived XenograftsJames Laird, Benjamin H Lok, Brandon Carney, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Therapy-associated mutagenesis at CTCF binding sites is shaped by chromatin context and DNA repair capacityKevin C L Cheng, Zoe P Klein, Jigyansa Mishra, et al.
Oral Oncology|August 18, 2016
High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neckSewit Teckie, Benjamin H Lok, Shyam Rao, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
The Utility of Liquid Biopsies in Radiation OncologySteven De Michino, Mansi Aparnathi, Ariana Rostami, et al.
Nature Reviews. Clinical Oncology|May 24, 2017
Unravelling the biology of SCLC: implications for therapyJoshua K Sabari, Benjamin H Lok, James H Laird, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|January 13, 2009
Gastric banding with simultaneous panniculectomy: two case reports on techniqueAllison M Carelli, Laki J Rousou, Benjamin H Lok, et al.
Cancer Medicine|January 1, 2019
Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignanciesJennifer Ma, James H Laird, Karen W Chau, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of InvolvementJames Laird, Jennifer Ma, Karen Chau, et al.
Cancer & Metabolism|June 24, 2026
CRISPR screen identifies autophagy inhibition (GNS561) as a PARP inhibitor (AZD5305) combination strategy in small cell lung cancerTony Yu, Ranya Barayan, Lifang Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and XenograftsJames H Laird, Benjamin H Lok, Jennifer Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived XenograftsJames Laird, Benjamin H Lok, Brandon Carney, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Therapy-associated mutagenesis at CTCF binding sites is shaped by chromatin context and DNA repair capacityKevin C L Cheng, Zoe P Klein, Jigyansa Mishra, et al.
Oral Oncology|August 18, 2016
High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neckSewit Teckie, Benjamin H Lok, Shyam Rao, et al.
Pageof 8